SEDANA logo

Sedana Medical AB (publ) Stock Price

OM:SEDANA Community·SEK 876.2m Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 5 Fair Values set on narratives written by author

SEDANA Share Price Performance

SEK 8.82
1.00 (12.79%)
SEK 21.00
Fair Value
SEK 8.82
1.00 (12.79%)
58.0% undervalued intrinsic discount
SEK 21.00
Fair Value
Price SEK 8.82
AnalystConsensusTarget SEK 21.00

SEDANA Community Narratives

AnalystConsensusTarget·
Fair Value SEK 21 58.0% undervalued intrinsic discount

US Entry And European Sales Will Expand Market Opportunity

0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
SEK 21
58.0% undervalued intrinsic discount
Profit Margin
10.19%
Future PE
65.23x
Price in 2028
SEK 24.61

Trending Discussion

Updated Narratives

SEDANA logo

US Entry And European Sales Will Expand Market Opportunity

Fair Value: SEK 21 58.0% undervalued intrinsic discount
4 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

High growth potential with excellent balance sheet.

2 Risks
1 Reward

Sedana Medical AB (publ) Key Details

SEK 200.2m

Revenue

SEK 57.5m

Cost of Revenue

SEK 142.7m

Gross Profit

SEK 202.0m

Other Expenses

-SEK 59.2m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Apr 15, 2026
-0.60
71.27%
-29.59%
0%
View Full Analysis

About SEDANA

Founded
1999
Employees
122
CEO
Johannes Doll
WebsiteView website
www.sedanamedical.com

Sedana Medical AB (publ), a medtech and pharmaceutical company, develops, manufactures, and sells medical devices and pharmaceutical products in Sweden, Germany, and internationally. The company offers Sedaconda ACD-L and Sedaconda ACD-S, which are disposable medical devices that enable the administration of volatile anaesthetics; Sedaconda Syringe, a 50/60ml syringe; Sedaconda ACD starter kit; Sedaconda (Isoflurane) for sedation of mechanically ventilated adult patients during intensive care; and AnaConDa, a medical device enabling the administration of inhaled anaesthetics. It also provides FlurAbsorb and FlurAbsorb-S, which are active carbon filters to capture waste anaesthetic gases from the exhaust of the ventilator; scavenging tube, a one-piece pre-connected tube designed to channel anaesthetic waste gas from the ventilator exhaust port and the gas monitor exhaust port to the FlurAbsorb filter; FlurAbsorb mount to hold the FlurAbsorb during scavenging of anaesthetic gas; FlurAbsorb-S mount to hold the FlurAbsorb-S during scavenging of anaesthetic gas; FlurAbsorb accessory kit comprising accessories to connect the exhaust of the ventilator and the gas monitor to FlurAbsorb/FlurAbsorb-S; and Mindray exhaust connector, which enables connection of the exhaust of the ventilator to an active or passive scavenging system. In addition, the company offers AMG-06 Gas Monitor for continuous non-invasive sidestream monitoring of CO2 and anaesthetics concentration in inspired and expired gases; Sedaconda Filling Adapter, a single-use device for safe and easy extraction of isoflurane from a Sedaconda bottle to a Sedaconda Syringe; and a single-use standard iso/sevo adapter that is designed to fit standard threaded isoflurane and sevoflurane bottles. Further, it provides DRYLINE II and WaterLock 2 water traps, Nafion dryer tubing, respiratory gas monitoring lines, and gas sampling line H products. The company was founded in 1999 and is headquartered in Danderyd, Sweden.

Recent SEDANA News & Updates

Sedana Medical AB (publ) (STO:SEDANA) Just Reported, And Analysts Assigned A kr19.00 Price Target

Feb 15
Sedana Medical AB (publ) (STO:SEDANA) Just Reported, And Analysts Assigned A kr19.00 Price Target

Recent updates

No updates